InvestorsHub Logo
Followers 87
Posts 8196
Boards Moderated 0
Alias Born 06/17/2013

Re: GoodMove post# 9244

Friday, 01/25/2019 7:15:43 PM

Friday, January 25, 2019 7:15:43 PM

Post# of 65749
Wes Chandler to lead Development of NeuroStilbene for CTE 8/22/18
Therapeutic Solutions International Recruits NFL Chargers Hall of Famer Wes Chandler to Lead NeuroStilbene for Chronic Traumatic Encephalopathy in Football Players
Company to Advance NeuroStilbene Product for High-Performance Athletes Susceptible to Head Injuries


https://ih.advfn.com/p.php?pid=nmona&article=78119448

Wes Chandler and Dr. Santosh Kesari collaborate on CTE Patent
after TSOI generates Proof of Concept Data using NeuroStilbene for Prevention of Football - Associated Brain Damage 9/19/18


https://ih.advfn.com/p.php?pid=nmona&article=78289796
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent TSOI News